Identifying Factors Underlying the Discontinuation of Triptans
NCT00890357 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 292
Last updated 2013-03-29
Summary
The objective of this study is to identify reasons migraine patients stop using triptan medications for abortive headache treatment. It is hypothesized that inadequate education of the patient at the time of prescribing the triptan is positively associated with triptan discontinuation.
Conditions
- Migraine
- Medication Adherence
Sponsors & Collaborators
- collaborator INDUSTRY
- lead OTHER
Principal Investigators
-
Todd Schwedt, MD · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-08-31
- Primary Completion
- 2012-06-30
- Completion
- 2012-06-30
Countries
- United States
Study Locations
More Related Trials
-
Comparing the Safety and Effectiveness of Topiramate With the Safety and Effectiveness of Amitriptyline in Preventing Migraine Headaches
NCT00210821 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Comprehensive Migraine Intervention
NCT01071317 ·Status: COMPLETED ·Phase: PHASE4
-
The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine
NCT01653522 ·Status: WITHDRAWN ·Phase: NA
-
A Quality of Life Study in Patients With Migraines
NCT00298805 ·Status: TERMINATED
-
Prediction of Migraine Prevention Efficacy Based on Individual's Pain Modulation
NCT02101892 ·Status: COMPLETED ·Phase: NA
-
Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellness Survey
NCT06680206 ·Status: COMPLETED
-
Study With Amitriptylin to Evaluate the Efficacy of Melatonin in Treatment of Migraine
NCT01357031 ·Status: COMPLETED ·Phase: PHASE3
-
Tryptophan as a Modulating Factor in the Antimigraine Efficacy of Triptans
NCT07177885 ·Status: RECRUITING
-
Treatment of Tinnitus With Migraine Medications
NCT04404439 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin Resistance in Women With Migraine
NCT01257893 ·Status: WITHDRAWN ·Phase: NA
-
An Open-label Study to Evaluate Topiramate Therapy in Migraine Patients, and Its Effects on Subject Responsiveness to Migraine Treatment With Triptans
NCT00261469 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches
NCT00210912 ·Status: COMPLETED ·Phase: PHASE3
-
ADX10059 Migraine Prevention Study
NCT00820105 ·Status: TERMINATED ·Phase: PHASE2
-
Retrospective Evaluation of Patient Failure to Follow-up at a Community Based Headache Clinic
NCT00690989 ·Status: COMPLETED
-
A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine
NCT00109083 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Decision Support for Patient Migraine Management
NCT03706794 ·Status: COMPLETED ·Phase: NA
-
Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women
NCT05854992 ·Status: COMPLETED
-
Detoxification and Treatment of Subjects With Medication Overuse Headache
NCT00432549 ·Status: UNKNOWN ·Phase: PHASE4
-
Exploring Clinical Trial Experiences of Patients With Migraine
NCT05675189 ·Status: NOT_YET_RECRUITING
-
The MOTS (Medication Overuse Treatment Strategy) Trial
NCT02764320 ·Status: COMPLETED ·Phase: NA
-
Coping Skills Training in Individuals With Migraine
NCT05809375 ·Status: UNKNOWN ·Phase: NA
-
Ibuprofen Versus Acetaminophen for Treatment of Mild Traumatic Brain Injury
NCT02443142 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Childhood and Adolescent Migraine Prevention Study
NCT01581281 ·Status: TERMINATED ·Phase: PHASE3
-
Management of Acute Tinnitus With Migraine Medications
NCT06799169 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Reliability of Rimegepant or Triptans for the Acute Treatment of Migraine
NCT06412965 ·Status: COMPLETED